A second-generation microRNA-based assay for diagnosing tumor tissue origin.

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Cancers of unknown primary (CUP) represent 3-5% of new cancer diagnoses annually in the US, posing significant diagnostic and treatment challenges.
• MicroRNAs, stable and tissue-specific, are promising biomarkers for identifying cancer origins.
• A first-generation assay identified 25 tumor types using 48 microRNAs via real-time PCR.

Purpose of the Study:

• To develop and validate a second-generation microRNA-based assay for identifying a broader range of tumor origins.
• To improve diagnostic accuracy and clinical utility for cancers of unknown or uncertain primary origin.

Main Methods:

• Development of a second-generation assay utilizing a custom microarray to detect 64 microRNAs.
• Implementation of a combined binary decision-tree and k-nearest-neighbor classifier for tumor origin identification.
• Validation on independent sample sets and a cohort of clinically diagnosed CUP patients.

Main Results:

• The assay demonstrated an overall sensitivity of 85% on 509 independent samples.
• Sensitivity reached 90% for cases with a single identified tumor type (over 80% of cases).
• An 88% concordance was observed in a clinical validation study with 52 CUP patients.

Conclusions:

• The second-generation assay accurately identifies 42 tumor types.
• The assay maintains high performance in samples from patients with clinically diagnosed CUP.
• This improved diagnostic tool promises enhanced utility for managing cancers of unknown/uncertain primary origins.